Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ: TWST )

51.14 +1.62 (+3.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Recap: Twist Bioscience Q2 Earnings
Via Benzinga
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Earnings Scheduled For May 5, 2023
Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly earnings at $0.32 per share on revenue of $5.08 billion. 
Via Benzinga
Earnings Preview: Twist Bioscience
Via Benzinga
3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers
Cathie Wood is loading up on these biotech stocks. 
Via The Motley Fool
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
From Twist Bioscience Corporation
Via Business Wire
Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought
The iconic money manager with a penchant for aggressive growth is staying active as her exchange-traded funds bounce back in 2023. 
Via The Motley Fool
The 7 Best Biotech Stocks for Personalized Medicine Investors
Personalized Medicine Stocks Promise to Make Healthcare More Individualized with therapeutics based on individual genetics. 
Via InvestorPlace
Where Twist Bioscience Stands With Analysts
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 345 companies set new 52-week lows. 
Via Benzinga
Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies
From Twist Bioscience Corporation
Via Business Wire
NVIDIA To Rally Over 31%? Here Are 10 Other Analyst Forecasts For Tuesday
Wells Fargo cut the price target for Marathon Oil Corporation (NYSE: MRO) from $40 to $38. Wells Fargo analyst Roger Read maintained an Overweight rating. Marathon Oil shares fell 0.3% to $24.72 in... 
Via Benzinga
Elliott Wave Technical Analysis: Twist Bioscience Corp. Friday, April 14
It has been moving perfectly ever since the last update. Looking for a continuation lower, even though it seems like we could be looking for support soon as we approach equality of (iii) vs. (i). 
Via Talk Markets
Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Report Fiscal 2023 Second Quarter Financial Results on Friday, May 5, 2023
From Twist Bioscience Corporation
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
  On Monday, 76 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 81 companies hit new 52-week lows. 
Via Benzinga
Elliott Wave Technical Analysis: Twist Bioscience Corp. - Wednesday, March 29
Looking for quick short trades into wave v. 
Via Talk Markets
DNA Data Storage Alliance Announces Board Appointments
From DNA Data Storage Alliance
Via Business Wire
Elliott Wave Technical Analysis: Twist Bioscience Corp.
Looking for further downside as we have an incomplete bearish sequence. 
Via Talk Markets
TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
NASDAQ:TWST Long Term Investor Alert: Investigation of Potential Wrongdoing at Twist Bioscience Corporation
San Diego, CA -- (SBWIRE) -- 03/15/2023 -- An investigation was announced for current long-term investors in shares of Twist Bioscience Corporation (NASDAQ:TWST) concerning potential breaches of... 
Via SBWire
Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
The Next Big Disruptors? 3 Biotech Stocks Making Headlines.
Biotech stocks were hard-hit in 2022, but these disruptive names in the field of synthetic biology can be big winners in 2023. 
Via InvestorPlace
Twist Bioscience Publishes Data on VHH Single Domain Antibody Discovery Using New Methodology on Optofluidic Platform
From Twist Bioscience Corporation
Via Business Wire
TWST FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action – TWST
From Rosen Law Firm
Via Business Wire
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Twist Bioscience Corporation (TWST) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)
From The Law Offices of Frank R. Cruz
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Iris, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.